XML 39 R3.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 17,618 $ 12,894
Restricted cash, current 1,178 722
Prepaid expenses and other current assets 1,897 2,732
Total current assets 20,693 16,348
Property and equipment, net 483 717
Operating lease, right-of-use assets 5,706 6,563
Restricted cash, noncurrent 696 685
Other long-term prepaid assets 600 2,833
Total assets 28,178 27,146
Current liabilities    
Accounts payable 1,038 4,369
Accrued expenses 8,415 3,757
Deferred research obligation 1,169 694
Operating lease liability, current 901 910
Unvested option exercise liability, current 0 25
Total current liabilities 11,523 9,755
Warrant liabilities 2,828 11
Operating lease liability, noncurrent 5,105 6,007
Convertible note - related party 20,034 0
Total liabilities 39,490 15,773
Commitments and contingencies—Note 10
Stockholders' (deficit) equity:    
Preferred stock, $0.01 par value; 10,000,000 shares authorized; no shares issued and outstanding 0 0
Common stock, $0.01 par value; 300,000,000 shares authorized; 11,043,837 and 9,618,178 shares issued at December 31, 2024 and 2023, respectively; 11,029,382 and 9,603,723 shares outstanding as of December 31, 2024 and 2023, respectively 110 96
Treasury stock, at cost, 14,455 shares outstanding (150) (150)
Additional paid-in capital 183,004 153,827
Accumulated other comprehensive loss (175) (197)
Accumulated deficit (194,101) (142,203)
Total stockholders' (deficit) equity (11,312) 11,373
Total liabilities, convertible preferred stock, and stockholders’ (deficit) equity $ 28,178 $ 27,146
Treasury stock, shares outstanding (in shares) 14,455 14,455